Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age who have a suspected or confirmed diagnosis of a rare liver tumour called relapsed/refractory hepatoblastoma (rrHBL), as determined by their treating cancer specialist or surgeon
- Children under 6 years of age at the time of their first diagnosis who have a type of liver cancer called Hepatocellular Malignant Neoplasm- Not Otherwise Specified (HCN-NOS) (confirm with trial site)
- People with a suspected rrHBL diagnosis may be eligible to join before a confirmed diagnosis, to allow fresh tumour tissue to be used for research modelling
- Written consent from the patient and/or a parent or legal guardian is required, unless the patient is deceased
Who may not be able to join:
- There are no listed exclusion criteria for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Katherine Somers, MD, Children's Hospital Medical Center, Cincinnati
Phone: 844-722-8774
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterization of relapsed or refractory Hepatoblastoma; Create biorepository of specimens; Clinical data and biological data correlation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.